Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
James Ermer,1 Mary B Haffey,1,† Cynthia Richards,1 Kenneth Lasseter,2 Ben Adeyi,1 Mary Corcoran,1 Beverly Stanton,1 Patrick Martin1 1Shire Development LLC, Wayne, PA, 2Clinical Pharmacology of Miami, Inc., Miami, FL, USA†This author is now deceasedBackground: Pharmacoki...
Main Authors: | Ermer J, Haffey MB, Richards C, Lasseter K, Adeyi B, Corcoran M, Stanton B, Martin P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/double-blind-placebo-controlled-two-period-crossover-trial-to-examine--a12192 |
Similar Items
-
Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation
by: Matthew D. Lyons MD, et al.
Published: (2017-05-01) -
Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
by: Paulo Mattos
Published: (2014-03-01) -
Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
by: Jadwiga Najib, et al.
Published: (2017-08-01) -
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
by: Michael Pennick
Published: (2010-06-01) -
Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
by: Weisler Richard, et al.
Published: (2009-08-01)